Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jan 18, 2022 4:25pm
117 Views
Post# 34330315

RE:Litigation is not an excuse to keep investors in the dark

RE:Litigation is not an excuse to keep investors in the darkLitigation is going nowhere.  They have had years to do something and you have heard nothing, absolutely nothing.

Stop talking about your fantasy.  While cure your wetdreams as well.


edrose wrote: Not an excuse to stop quarterly conference calls and having Q& A
they probably don't want investors to ask them questions since afraid of getting into more legal problems   They will have to answer under oath 

litigation is also not valid reason to put 4050 on hold and tell investors it's because we have to analy Pk data  wonder what they will say under oath since lying under oath has serious consequences and we know scientists will say the truth ie it doesn't take several months to analyze pk data on the few patients they had in study  
scientists will probably state and name the people who told them to stall research 

just an opinion
WHAT DO OTHER PEOPLE THINK 


<< Previous
Bullboard Posts
Next >>